Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda et al.
Ann Rheum Dis
; 82(2): e35, 2023 Feb.
Article
in En
| MEDLINE
| ID: mdl-33318060
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Ann Rheum Dis
Year:
2023
Document type:
Article
Affiliation country:
Países Bajos